Stay updated on Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Sign up to get notified when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.

Latest updates to the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision label updated to v3.5.4 in the Study Record Versions, replacing the previous v3.5.3. This update reflects a metadata change in the study history rather than substantive content.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA minor update to the page’s internal revision/version label (from v3.5.2 to v3.5.3) without changing the study’s displayed record information.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded revision v3.5.2 to the history and removed the previous v3.5.0 entry.SummaryDifference0.1%

- Check75 days agoChange DetectedA new version entry (v3.5.0) was added with updates to Study Status and Contacts/Locations, and an older revision (v3.4.3) was removed.SummaryDifference0.4%

- Check83 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check111 days agoChange DetectedA new revision entry for v3.4.2 was added to the record history and the v3.4.1 entry was removed. This appears to be a site maintenance/update rather than a modification to study data.SummaryDifference0.1%

Stay in the know with updates to Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ziftomenib Combination in AML: Safety & Tolerability Clinical Trial page.